Written and maintained by CASRAI Editorial Board
Last updated
The EQ-5D-5L is a standardized, preference-based generic instrument developed by the EuroQol Group (introduced by Herdman et al., 2011 in Quality of Life Research, 20(10), 1727–1736) to measure health-related quality of life (HRQoL) in clinical trials, population health surveys, and health technology assessments (HTAs). Unlike non-preference profile questionnaires that produce only domain summary scores, the EQ-5D-5L maps a respondent’s self-reported 5-digit health state profile into a single country-specific health state utility index anchored at 1.000 (full health) and 0.000 (dead)—enabling direct calculation of Quality-Adjusted Life Years (QALYs) in Cost-Utility Analysis (CUA) alongside complementary instruments such as the SF-36.
What Is EQ-5D-5L and How Is It Used in Clinical Research and Healthcare?
Every EQ-5D-5L questionnaire consists of two distinct components administered on paper or via electronic patient-reported outcome measures (PROMs / ePRO):
1. The EQ-5D-5L Descriptive System (5 Dimensions × 5 Levels = 3,125 Health States)
The respondent rates their health “TODAY” across five core dimensions, selecting one of five severity levels for each dimension. Whereas the legacy 1990 EQ-5D-3L offered only 3 levels per dimension ($3^5 = 243$ health states) and suffered from severe ceiling effects in mild-to-moderate chronic disease, Herdman et al. (2011) expanded each dimension to 5 levels, yielding 55 = 3,125 unique health states:
| Dimension Order | EQ-5D-5L Dimension | Level 1 | Level 2 | Level 3 | Level 4 | Level 5 |
|---|---|---|---|---|---|---|
| Digit 1 (MO) | Mobility | No problems walking about | Slight problems walking about | Moderate problems walking about | Severe problems walking about | Unable to walk about |
| Digit 2 (SC) | Self-Care | No problems washing or dressing myself | Slight problems washing or dressing myself | Moderate problems washing or dressing myself | Severe problems washing or dressing myself | Unable to wash or dress myself |
| Digit 3 (UA) | Usual Activities (work, study, housework, family/leisure) | No problems doing my usual activities | Slight problems doing my usual activities | Moderate problems doing my usual activities | Severe problems doing my usual activities | Unable to do my usual activities |
| Digit 4 (PD) | Pain / Discomfort | No pain or discomfort | Slight pain or discomfort | Moderate pain or discomfort | Severe pain or discomfort | Extreme pain or discomfort |
| Digit 5 (AD) | Anxiety / Depression | Not anxious or depressed | Slightly anxious or depressed | Moderately anxious or depressed | Severely anxious or depressed | Extremely anxious or depressed |
Concatenating the five selected levels in strict order (MO–SC–UA–PD–AD) produces a 5-digit health state profile. For example, profile 11111 denotes no problems in any dimension (full health), profile 11232 denotes no problems in Mobility or Self-Care, slight problems in Usual Activities, moderate Pain/Discomfort, and slight Anxiety/Depression, and profile 55555 denotes the worst possible health state across all five domains. Crucially, the 5-digit code 11232 is a categorical label—not an cardinal number—and cannot be summed or averaged directly.
2. The EQ Visual Analogue Scale (EQ VAS)
On the second page, the patient records their overall self-rated health status on a vertical 20-centimeter hash-marked thermometer scale ranging from 0 (“The worst health you can imagine”) to 100 (“The best health you can imagine”). Unlike the 5-dimension index score (which applies societal preference weights), the EQ VAS captures the individual patient’s direct subjective valuation on a continuous 0–100 metric.
Converting EQ-5D-5L Profiles into Index Utilities (U.S. Pickard 2019 cTTO Value Set)
To use EQ-5D-5L data in pharmacoeconomic modeling and QALY calculations, the 5-digit profile must be converted into a single summary EQ-5D-5L Index Score (utility weight) using a country-specific value set elicited from the general population via the EuroQol Valuation Technology (EQ-VT) protocol, which combines composite Time Trade-Off (cTTO) interviews and Discrete Choice Experiments (DCE).
In the official United States EQ-5D-5L Value Set published by A. Simon Pickard et al. (2019, Value in Health, 22(8), 931–941; N = 1,062 U.S. adult general population respondents), utility decrements are subtracted from 1.000 using an additive 20-parameter main-effects Tobit model:
| Severity Level | Mobility (MO) Decrement | Self-Care (SC) Decrement | Usual Activities (UA) Decrement | Pain / Discomfort (PD) Decrement | Anxiety / Depression (AD) Decrement |
|---|---|---|---|---|---|
| Level 1 (None) | 0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
| Level 2 (Slight) | -0.096 |
-0.089 |
-0.068 |
-0.060 |
-0.057 |
| Level 3 (Moderate) | -0.122 |
-0.107 |
-0.101 |
-0.098 |
-0.123 |
| Level 4 (Severe) | -0.237 |
-0.220 |
-0.255 |
-0.318 |
-0.299 |
| Level 5 (Unable / Extreme) | -0.322 |
-0.261 |
-0.255 |
-0.414 |
-0.321 |
- Worked Calculation Example (U.S. Pickard 2019 Value Set):
- Health State `11111` (Full Health): U = 1.000 − (0 + 0 + 0 + 0 + 0) = 1.000.
- Health State `11232`: U = 1.000 − (0.000 + 0.000 + 0.068 + 0.098 + 0.057) = 1.000 − 0.223 = 0.777.
- Health State `55555` (Worst Possible State): U = 1.000 − (0.322 + 0.261 + 0.255 + 0.414 + 0.321) = 1.000 − 1.573 = −0.573. (Any utility score below
0.000indicates a health state that societal respondents value as worse than being dead under lead-time cTTO).
What Standards, HTA Guidelines, and Licensing Rules Govern EQ-5D-5L?
Investigators incorporating EQ-5D-5L into clinical trial protocols and regulatory submissions must comply with three governance frameworks:
- EuroQol Research Foundation Registration and ePRO Licensing: The wording, layout, and translations of EQ-5D-5L are strictly copyrighted by the EuroQol Research Foundation. All studies—whether non-commercial academic trials (which generally qualify for free registration) or commercial pharmaceutical/device trials (which require a licensing fee)—must register their study with EuroQol before administration. Furthermore, digital implementations on mobile apps or web portals must use EuroQol-certified ePRO screenshots and cannot alter question phrasing, response order, or the `TODAY` recall period.
- HTA Agency Value Set Selection (ICER, CADTH, NICE): Health technology assessment bodies require using the value set matched to the decision jurisdiction—such as Pickard et al. (2019) for U.S. Institute for Clinical and Economic Review (ICER) models or Xie et al. (2016) for Canadian CADTH submissions. In England and Wales, the National Institute for Health and Care Excellence (NICE) historically required mapping (`crosswalking`) EQ-5D-5L responses onto the EQ-5D-3L value set using the van Hout et al. (2012) transition probability matrix (or the Hernandez Alava et al. mapping model) pending updated UK valuation standards.
- Minimal Clinically Important Difference (MCID): Across chronic disease cohorts, published anchor- and distribution-based MCID estimates for the EQ-5D-5L Index Score typically range from 0.03 to 0.08 utility units (with a U.S. mean baseline estimate around
0.04–0.07depending on disease severity), and 7 to 10 points on the `0–100` EQ VAS.
How Does EQ-5D-5L Integrate with EHR and Health Informatics Workflows?
In hospital PROM validation registries (such as the NHS England National PROMs Programme for hip and knee arthroplasty) and FHIR-enabled electronic health records, EQ-5D-5L is represented using HL7 FHIR R4 Questionnaire and QuestionnaireResponse resources:
- Each of the 5 dimensions is stored as a coded ordinal item (
1to5), the EQ VAS is stored as an integer quantity (0–100), and an embedded scoring algorithm (or CDISC ADaM `ADQS` script in clinical trials) computes both the 5-digit health state string (e.g.,"11232") and the country-specific utility index as derivedObservationresources.
Frequently Asked Questions
Why can an EQ-5D-5L utility score be negative?
In health economics, utility scores are anchored at 1.0 for full health and 0.0 for dead. During composite Time Trade-Off (cTTO) valuation interviews, when general population participants indicate they would prefer immediate death over living for 10 years in a state of extreme pain, immobility, and helplessness (trading away “lead time” in full health to avoid that state), the resulting utility weight is negative (down to -0.573 for state 55555 in the U.S. Pickard 2019 value set).
What is the difference between EQ-5D-3L, EQ-5D-5L, and EQ-5D-Y?
EQ-5D-3L is the original 3-level adult version (none, some, extreme/unable; 243 states). EQ-5D-5L is the 5-level adult version (none, slight, moderate, severe, extreme/unable; 3,125 states) offering superior sensitivity and reduced ceiling effects. EQ-5D-Y (Youth) adapts the dimension wording for children and adolescents aged 8–15 years (with a proxy version for ages 4–7).
How are QALYs calculated from longitudinal EQ-5D-5L measurements?
In a longitudinal clinical trial where EQ-5D-5L is administered at baseline, Month 3, Month 6, and Month 12, total Quality-Adjusted Life Years (QALYs) are calculated using the Area Under the Curve (AUC) trapezoidal rule—multiplying the average utility index between consecutive visits by the fraction of a year elapsed between those visits, typically adjusted for baseline utility imbalances via linear regression.
